Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1

The clinical heterogeneity of prostate cancer (PCa) makes it difficult to identify those patients that could benefit from more aggressive treatments. As a contribution to a better understanding of the genomic changes in the primary tumor that are associated with the development of high-risk disease,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Spans, Lien, Van den Broeck, Thomas, Smeets, Elien, Prekovic, Stefan, Thienpont, Bernard, Lambrechts, Diether, Karnes, R. Jeffrey, Erho, Nicholas, Alshalalfa, Mohammed, Davicioni, Elai, Helsen, Christine, Gevaert, Thomas, Tosco, Lorenzo, Haustermans, Karin, Lerut, Evelyne, Joniau, Steven, Claessens, Frank
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5029704/
https://ncbi.nlm.nih.gov/pubmed/27014907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8220
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki